GL1X · GenesisL1 explorer

MolNFT v1 · #62621 · protein

Crystal structure of the inhibitor atazanavir (atv) in complex with a multi-drug resistance HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A) refer: flap+ in citation.

3EKW: “Crystal structure of the inhibitor atazanavir (atv) in complex with a multi-drug resistance HIV-1 protease…”. X-ray diffraction, 2 ligands (DR7, PO4), 1 pocket (best druggability 0.72). MolNFT v1 #62621 on GenesisL1: 3D structure…

PDB
3EKW
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P03369
Ligands
DR7, PO4
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein994% helix, 54% strandP03369

Ligands and binding sites

  • DR7 · (3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5, 6,10,13-pentaazatetradecanedioic acid dimethyl ester · ligand · chains A, B
  • PO4 · Phosphate ion · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14410.720.8246DR7

Interfaces

1 interface between chains.

  • A–B · 1849 Ų buried · 39 hydrogen bonds · protein-protein

Compared structures

  • 3EKW · Crystal structure of the inhibitor Atazanavir (ATV) in complex with a multi-drug… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.